Global Real World Evidence Solutions Market

Global Real World Evidence Solutions Market Size, Share, Growth Analysis, By Component(Service, data sets), By Application(Drug Development & Approvals, Medical Device Development & Approvals), By End user(Pharmaceutical & Medical Device Companies, Healthcare Payers) - Industry Forecast 2024-2031

Report ID: SQMIG35I2180 | Region: Global | Published Date: April, 2024
Pages: 242 | Tables: 90 | Figures: 76

Global Real World Evidence Solutions Market Regional Insights

North America dominated the market and accounted for the largest revenue share of over 40.2% in 2021. The presence of important players in the U.S. is credited with the region’s large share. Growing RWE service providers and supportive local government policies are also anticipated to support industry expansion. Additionally, the switch from volume to value-based treatment is anticipated to boost industry expansion. In addition, the ageing population and the subsequent rise in chronic disease prevalence are major drivers of this market’s expansion. The market is expected to grow as a result of favourable government laws and the rising number of RWE service providers in North America.

Asia Pacific is fastest growing region and expected to expand at the fastest CAGR during the forecast period. Because of the growing government initiatives to embrace RWE studies and the prevalence of numerous contract research and manufacturing businesses in nations like China and India. Additionally predicted to propel market growth is rising consumer desire for better healthcare services.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Real World Evidence Solutions Market size was valued at USD 2.26 billion in 2019 and is poised to grow from USD 2.45 billion in 2023 to USD 4.97 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

Global Real World Evidence Solutions Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'IQVIA Inc.', 'Optum, Inc.', 'IBM Corporation', 'Syneos Health, Inc.', 'PPD, Inc.', 'Cognizant Technology Solutions Corporation', 'Oracle Corporation', 'Anthem, Inc.', 'Clinigen Group PLC', 'Change Healthcare Inc.', 'Pharmaceutical Product Development, LLC (PPD)', 'Evidera, Inc.', 'HealthVerity, Inc.', 'ICON plc', 'Medidata Solutions, Inc.', 'Flatiron Health, Inc.', 'Pharmerit International LP', 'COTA, Inc.', 'Aetion, Inc.', 'OM1, Inc.'

Reducing drug development costs and expediting the drug development process

The increasing focused on end to end real world services are increased demand. This has opened the door for an end-to-end strategy that makes the most of a life sciences organization’s data, evidence, and knowledge assets while dissolving conventional silos and enabling insight-driven decision-making from R&D to the product commercialization stage. This entails putting in place a sound governance structure, utilising tools like cloud and self-service analytics, and enabling the capacity to combine data sets and identify the right resources for the required analyses.

North America dominated the market and accounted for the largest revenue share of over 40.2% in 2021. The presence of important players in the U.S. is credited with the region’s large share. Growing RWE service providers and supportive local government policies are also anticipated to support industry expansion. Additionally, the switch from volume to value-based treatment is anticipated to boost industry expansion. In addition, the ageing population and the subsequent rise in chronic disease prevalence are major drivers of this market’s expansion. The market is expected to grow as a result of favourable government laws and the rising number of RWE service providers in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Real World Evidence Solutions Market

Report ID: UCMIG35I2179 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Personalized Nutrition And Supplements Market
Buy Now GET FREE SAMPLE
Global Real World Evidence Solutions Market

Report ID: UCMIG35I2219 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Nanoparticles - Metal & Metal Oxides Market
Buy Now GET FREE SAMPLE
Global Real World Evidence Solutions Market

Report ID: UCMIG35I2155 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Herpes Simplex Virus Treatment Market
Buy Now GET FREE SAMPLE
Global Real World Evidence Solutions Market

Report ID: SQMIG35I2103 | Region: Global | Published Date: April, 2024 | Pages: 219 | Tables: 65 | Figures: 75

Global Cholera Vaccines Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Real World Evidence Solutions Market

Product ID: SQMIG35I2180

$5,300
BUY NOW GET FREE SAMPLE